Patent US4861727A successfully refreshed from Google Patents.
US4861727A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Luminescent oxygen sensor based on a lanthanide complex
Assignee: CR Bard Inc
•
Filing: 1986-09-08
•
Granted: 1989-08-29
•
Expires: 2006-09-08
Abstract
Abstract An oxygen sensor is provided for determination of the partial pressure of oxygen. In one aspect, the invention consists of oxygen-quenchable luminescent lanthanide complexes for an oxygen sensor. The complexes are oxygen-quenchable even though immobilized in a solid matrix, such as a solid polymeric matrix, and preferably are terbium complexes of Schiff base or β-diketone ligands. Certain preferred processes are described for improving the oxygen sensitivity of the lanthanide complexes. In another aspect, the invention consists of a combination measuring and reference analyte sensor containing both quenchable and nonquenchable luminescent materials. The materials luminesce at different wavelengths and thus may be transmitted together down a single optical fiber and later descriminated by means of filters and separately detected. In a third aspect, the invention consists of a low-noise phosphorescent analyte sensor employing a gatable detector. By use of an analyte-quenchable material having a relatively long-lived phosphorescence, a pulsed excitation source, and selectively coupling the detector after the excitation source is off and any short-lived background luminescence has ended, a low-noise output signal consisting of the long-lived phosphorescence is selectively detected and the concentration of the analyte determined therefrom. In a preferred embodiment, all aspects of the invention are combined to produce a miniature in vivo oxygen sensor for use in the narrow blood vessels of the body.
Inventors
- 👤 Bennett L. Hauenstein
- 👤 Raysna Picerno
- 👤 Harry G. Brittain
- 👤 James R. Nestor
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:08
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6428; G01N21/643; A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/1459; C; C09; C09K; C09K11/00; C09K11/06; G01N21/6408; G01N2021/641; G01N2021/6432; G01N2021/6434; G01N21/645; G01N2021/6484; G01N21/75; G01N21/77; G01N21/7703; G01N2021/7706; G01N2021/772; G01N2021/7769; G01N2021/7786; Y; Y10; Y10T; Y10T436/00; Y10T436/20; Y10T436/207497
Claims Analysis
Total Claims: 49
Claim 1
Independent Claim
66 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex which is contained in an oxygen-permeable, solid polymeric matrix to said sample and to radiation which causes said lanthanide complex to luminesce and detecting a change in the luminescence intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas.
Claim 2
Independent Claim
66 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex which is contained in an oxygen-permeable, solid polymeric matrix to said sample and to radiation which causes said lanthanide complex to luminesce and detecting a change in the luminescence intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas.
Claim 3
Dependent Claim
13 words
The method of claim 1, wherein said method is carried out in vivo.
Claim 4
Dependent Claim
23 words
The method of claim 1, wherein said lanthanide complex is prepared by complexing said ligand and lanthanide ion in the presence of hydroxide.
Claim 5
Dependent Claim
40 words
The method of claim 1, wherein said lanthanide complex comprises at least one lanthanide ion complexed with at least one ligand, and said lanthanide complex is prepared by deprotonating said ligand with hydroxide before complexing said ligand and lanthanide ion.
Claim 6
Dependent Claim
23 words
The method of claim 4, wherein said lanthanide complex is prepared by complexing said ligand and lanthanide ion in the presence of hydroxide.
Claim 7
Dependent Claim
35 words
The method of claim 5 wherein said lanthanide complex is further prepared by disolving the lanthanide complex in an organic solvent, filtering off the nonsoluble impurities which are less oxygen sensitive, and reprecipitating the complex.
Claim 8
Dependent Claim
36 words
The method of claim 1, wherein said lanthanide complex is a terbium complex of at least one terbium ion complexed with at least one ligand selected from the group consisting of Schiff base and β-diketone ligands.
Claim 9
Dependent Claim
23 words
The method of claim 7, wherein said ligand is a β-diketone ligand selected from the group consisting of: benzoylacetone; thenoyltrifluoroacetone; trifluoroacetylacetone; and furylbutanedione.
Claim 10
Dependent Claim
18 words
The method of claim 8 wherein said method is used for determining the oxygen concentraion of the blood.
Claim 11
Dependent Claim
24 words
The method of claim 7, wherein said ligand is a Schiff base ligand comprising at least one aldehyde and at least one primary amine.
Claim 12
Dependent Claim
19 words
The method of claim 10, wherein said aldehyde is selected from the group consisting of salicylaldehyde and substituted salicylaldehyde.
Claim 13
Dependent Claim
22 words
The method of claim 11, wherein said primary amine is selected from the group consisting of 1-amino-2-propanol, 1-amino-2-butanol, 2-amino-1-phenyl-1,2-propanediol, ethylenediamine, and propylenediamine.
Claim 14
Dependent Claim
45 words
The method of claim 12, wherein said Schiff base ligand is selected from the group consisting of: 1:1 salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 1-amino-2-butanol; 1:1 5-chloro-salicylaldehyde: 1-amino-2-propanol; 1:1 3,5-dichloro-salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 2-amino-1-phenyl-1,2-propanediol; 2:1 salicylaldehyde: ethylenediamine; 2:1 salicylaldehyde: propylenediamine; 1:1 o-vanillin: 1-amino-2-propanol; and 1:1 m-vanillin: 1-amino-2-propanol.
Claim 15
Dependent Claim
18 words
The method of claim 13, wherein said method is used for determining the oxygen concentration of the blood.
Claim 16
Independent Claim
89 words
An apparatus for measuring the concentration of oxygen gas in a sample comprising: a lanthanide complex contained in a solid polymeric matrix which is permeable to oxygen gas and wherein said lanthanide complex emits a luminescence when exposed to an incident energy signal in a predetermined wavelength range and which luminescence is quenched by oxygen gas; source means coupled to said luminescence material for generating the incident energy signal to cause said lanthanide complex to luminesce; and detector means coupled to said lanthanide complex for detecting the luminescence therefrom.
Claim 17
Independent Claim
89 words
An apparatus for measuring the concentration of oxygen gas in a sample comprising: a lanthanide complex contained in a solid polymeric matrix which is permeable to oxygen gas and wherein said lanthanide complex emits a luminescence when exposed to an incident energy signal in a predetermined wavelength range and which luminescence is quenched by oxygen gas; source means coupled to said luminescence material for generating the incident energy signal to cause said lanthanide complex to luminesce; and detector means coupled to said lanthanide complex for detecting the luminescence therefrom.
Claim 18
Dependent Claim
32 words
The apparatus of claim 15, wherein said lanthanide complex comprises at least one terbium ion complexed with at least one ligand selected from the group consisting of Schiff base and β-diketone ligands.
Claim 19
Dependent Claim
35 words
The apparatus of claim 15, further comprising an optical fiber for transmitting the incident energy signal from said source means to said lanthanide complex and the luminescence from said lanthanide complex to said detector means.
Claim 20
Dependent Claim
23 words
The apparatus of claim 17, wherein said optical fiber is disposed in a carrier means for use as an in vivo oxygen sensor.
Claim 21
Dependent Claim
38 words
An oxygen gas sensor comprising an oxygen-quenchable luminescent lanthanide complex of at least one lanthanide ion complexed with at least one Schiff base ligand and detector means operatively connected to said complex for detecting oxygen-quenching of said complex.
Claim 22
Dependent Claim
38 words
An oxygen gas sensor comprising an oxygen-quenchable luminescent lanthanide complex of at least one lanthanide ion complexed with at least one Schiff base ligand and detector means operatively connected to said complex for detecting oxygen-quenching of said complex.
Claim 23
Dependent Claim
21 words
The sensor of claim 19, wherein said Schiff base ligand comprises at least one aldehyde and at least one primary amine.
Claim 24
Dependent Claim
19 words
The sensor of claim 20, wherein said aldehyde is selected from the group consisting of salicylaldehyde and substituted salicylaldehyde.
Claim 25
Dependent Claim
22 words
The sensor of claim 21, wherein said primary amine is selected from the group consisting of 1-amino-2-propanol, 1-amino-2-butanol, 2-amino-1-phenyl-1,2-propanediol, ethylenediamine, and propylenediamine.
Claim 26
Dependent Claim
45 words
The sensor of claim 22, wherein said Schiff base ligand is selected from the group consisting of: 1:1 salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 1-amino-2-butanol; 1:1 5-chloro-salicylaldehyde: 1-amino-2-propanol; 1:1 3,5-dichloro-salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 2-amino-1-phenyl-1,2-propanediol; 2:1 salicylaldehyde: ethlenediamine; 2:1 salicylaldehyde: propylenediamine; 1:1 o-vanillin: 1-amino-2-propanol; and 1:1 m-vanillin: 1-amino-2-propanol.
Claim 27
Dependent Claim
22 words
The sensor of claim 23, wherein said lanthanide complex is contained in a solid polymeric matrix which is permeable to oxygen gas.
Claim 28
Dependent Claim
22 words
The sensor of claim 24, wherein said lanthanide complex comprises a terbium complex adapted for determining the oxygen concentration of the blood.
Claim 29
Dependent Claim
13 words
The sensor of claim 19, wherein said lanthanide complex further comprises hydroxide ligands.
Claim 30
Independent Claim
75 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex to said sample and to radiation which causes said lanthanide complex to luminesce and detecting a change in the luminescence intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas, wherein said lanthanide complex comprises at least one lanthanide ion complexed with at least one Schiff base ligand.
Claim 31
Independent Claim
75 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex to said sample and to radiation which causes said lanthanide complex to luminesce and detecting a change in the luminescence intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas, wherein said lanthanide complex comprises at least one lanthanide ion complexed with at least one Schiff base ligand.
Claim 32
Dependent Claim
21 words
The method of claim 27, wherein said Schiff base ligand comprises at least one aldehyde and at least one primary amine.
Claim 33
Dependent Claim
19 words
The method of claim 28, wherein said aldehyde is selected from the group consisting of salicylaldehyde and substituted salicylaldehyde.
Claim 34
Dependent Claim
22 words
The method of claim 29, wherein said primary amine is selected from the group consisting of 1-amino-2-propanol, 1-amino-2-butanol, 2-amino-1-phenyl-1,2-propanediol, ethylenediamine, and propylenediamine.
Claim 35
Dependent Claim
45 words
The method of claim 30, wherein said Schiff base ligand is selected from the group consisting of: 1:1 salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 1-amino-2-butanol; 1:1 5-chloro-salicylaldehyde: 1-amino-2-propanol; 1:1 3,5-dichloro-salicylaldehyde: 1-amino-2-propanol; 1:1 salicylaldehyde: 2-amino-1-phenyl-1,2-propanediol; 2:1 salicylaldehyde: ethylenediamine; 2:1 salicylaldehyde: propylenediamine; 1:1 o-vanillin: 1-amino-2-propanol; and 1:1 m-vanillin: 1-amino-2-propanol.
Claim 36
Dependent Claim
18 words
The method of claim 31, wherein said method is used for determining the oxygen concentration of the blood.
Claim 37
Dependent Claim
27 words
An oxygen gas sensor comprising an oxygen-quenchable luminescent lanthanide complex in solid form and detector means operatively connected to said complex for detecting oxygen-quenching of said complex.
Claim 38
Dependent Claim
27 words
An oxygen gas sensor comprising an oxygen-quenchable luminescent lanthanide complex in solid form and detector means operatively connected to said complex for detecting oxygen-quenching of said complex.
Claim 39
Dependent Claim
12 words
The sensor of claim 33, wherein said lanthanide complex includes hydroxide ligands.
Claim 40
Dependent Claim
23 words
The sensor of claim 33, wherein said lanthanide complex comprises at least one lanthanide ion complexed with at least one Schiff base ligand.
Claim 41
Dependent Claim
37 words
The sensor of claim 35, wherein said lanthanide ion is terbium and said Schiff base ligand comprises at least one primary amine and at least one aldehyde selected from the group consisting of salicylaldehyde and substituted salicylaldehyde.
Claim 42
Dependent Claim
27 words
The sensor of claim 36, wherein the lanthanide complex comprises three terbium +3 ions, three hydroxides, and three Schiff base ligands of the formula 1:1 salicylaldehyde: 2-amino-1-phenyl-1,2-propane-diol.
Claim 43
Independent Claim
60 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex in solid form to said sample and to radiation which causes said lanthanide complex to luminesce and detecting the change in the luminescent intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas.
Claim 44
Independent Claim
60 words
A method for detecting the presence or determining the concentration of oxygen gas in a sample comprising exposing an oxygen-quenchable luminescent lanthanide complex in solid form to said sample and to radiation which causes said lanthanide complex to luminesce and detecting the change in the luminescent intensity emitted by said lanthanide complex resulting from said exposure to said oxygen gas.
Claim 45
Dependent Claim
18 words
The method of claim 38, wherein said method is used for determining the oxygen concentration of the blood.
Claim 46
Dependent Claim
12 words
The method of claim 39, wherein said lanthanide complex includes hydroxide ligands.
Claim 47
Dependent Claim
23 words
The method of claim 39, wherein said lanthanide complex comprises at least one lanthanide ion complexed with at least one Schiff base ligand.
Claim 48
Dependent Claim
37 words
The method of claim 41, wherein said lanthanide ion is terbium and said Schiff base ligand comprises at least one primary amine and at least one aldehyde selected from the group consisting of salicylaldehyde and substituted salicylaldehyde.
Claim 49
Dependent Claim
27 words
The method of claim 42, wherein said lanthanide complex comprises three terbium +3 ions, three hydroxides, and three Schiff base ligands of the formula 1:1 salicylaldehyde: 2-amino-1-phenyl-1,2-propane-diol.
References Cited (Backward Citations)
US31879A
Cited
DE106086C
Cited
US4037172A
Cited
US3440173A
Cited
US3377292A
Cited
US3484380A
Cited
US3422023A
Cited
US3612866A
Cited
US3971941A
Cited
USRE31879E
Cited
US4321057A
Cited
US4399099A
Cited
US4560248A
Cited
US4476870A
Cited
GB2132398A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-08-28 | 1993-02-27 | 1993-08-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-08-28 | 1997-02-27 | 1997-08-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-08-28 | 2001-02-27 | 2001-08-29 | $7700.00 | Window Closed / Lapsed |